๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C

โœ Scribed by Nagaoki, Yuko; Imamura, Michio; Kawakami, Yoshiiku; Kan, Hiromi; Fujino, Hatsue; Fukuhara, Takayuki; Kobayashi, Tomoki; Ono, Atsushi; Nakahara, Takashi; Naeshiro, Noriaki; Urabe, Ayako; Yokoyama, Satoe; Miyaki, Daisuke; Murakami, Eisuke; Kawaoka, Tomokazu; Tsuge, Masataka; Hiramatsu, Akira; Aikata, Hiroshi; Takahashi, Shoichi; Hayes, C. Nelson; Ochi, Hidenori; Chayama, Kazuaki

Book ID
121654109
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
486 KB
Volume
44
Category
Article
ISSN
1386-6346

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pegylated interferon and ribavirin thera
Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
โœ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-Saunรฉ; J.P. Vinel; L. A ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCVโ€4 responds poorly to interferon. Pegylated

Interleukin 28B polymorphism predicts pe
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4
โœ Stella De Nicola; Alessio Aghemo; Maria Grazia Rumi; Enrico Galmozzi; Luca Valen ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 499 KB ๐Ÿ‘ 1 views

Single nucleotide polymorphisms (SNPs) near the interleukin 28B (IL28B) region are the strongest baseline predictors of a sustained virologic response (SVR) to peg-interferon (PegIFN) and ribavirin (Rbv) in patients with hepatitis C virus (HCV) genotype 1 infection. Whether this holds true for HCV-4